TY - JOUR
T1 - Predictors and costs of surgical site infections in patients with endometrial cancer
AU - Bakkum-Gamez, Jamie N.
AU - Dowdy, Sean C.
AU - Borah, Bijan J.
AU - Haas, Lindsey R.
AU - Mariani, Andrea
AU - Martin, Janice R.
AU - Weaver, Amy L.
AU - McGree, Michaela E.
AU - Cliby, William A.
AU - Podratz, Karl C.
N1 - Funding Information:
Funding source: This work was partially supported by the Office of Women's Health Research Building Interdisciplinary Careers in Women's Health (BIRCWH award K12 HD065987).
PY - 2013/7
Y1 - 2013/7
N2 - Objective Technological advances in surgical management of endometrial cancer (EC) may allow for novel risk modification in surgical site infection (SSI). Methods Perioperative variables were abstracted from EC cases surgically staged between January 1, 1999, and December 31, 2008. Primary outcome was SSI, as defined by American College of Surgeons National Surgical Quality Improvement Program. Counseling and global models were built to assess perioperative predictors of superficial incisional SSI and organ/space SSI. Thirty-day cost of SSI was calculated. Results Among 1369 EC patients, 136 (9.9%) had SSI. In the counseling model, significant predictors of superficial incisional SSI were obesity, American Society of Anesthesiologists (ASA) score > 2, preoperative anemia (hematocrit < 36%), and laparotomy. In the global model, significant predictors of superficial incisional SSI were obesity, ASA score > 2, smoking, laparotomy, and intraoperative transfusion. Counseling model predictors of organ/space SSI were older age, smoking, preoperative glucose > 110 mg/dL, and prior methicillin-resistant Staphylococcus aureus (MRSA) infection. Global predictors of organ/space SSI were older age, smoking, vascular disease, prior MRSA infection, greater estimated blood loss, and lymphadenectomy or bowel resection. SSI resulted in a $5447 median increase in 30-day cost. Conclusions Our findings are useful to individualize preoperative risk counseling. Hyperglycemia and smoking are modifiable, and minimally invasive surgical approaches should be the preferred surgical route because they decrease SSI events. Judicious use of lymphadenectomy may decrease SSI. Thirty-day postoperative costs are considerably increased when SSI occurs.
AB - Objective Technological advances in surgical management of endometrial cancer (EC) may allow for novel risk modification in surgical site infection (SSI). Methods Perioperative variables were abstracted from EC cases surgically staged between January 1, 1999, and December 31, 2008. Primary outcome was SSI, as defined by American College of Surgeons National Surgical Quality Improvement Program. Counseling and global models were built to assess perioperative predictors of superficial incisional SSI and organ/space SSI. Thirty-day cost of SSI was calculated. Results Among 1369 EC patients, 136 (9.9%) had SSI. In the counseling model, significant predictors of superficial incisional SSI were obesity, American Society of Anesthesiologists (ASA) score > 2, preoperative anemia (hematocrit < 36%), and laparotomy. In the global model, significant predictors of superficial incisional SSI were obesity, ASA score > 2, smoking, laparotomy, and intraoperative transfusion. Counseling model predictors of organ/space SSI were older age, smoking, preoperative glucose > 110 mg/dL, and prior methicillin-resistant Staphylococcus aureus (MRSA) infection. Global predictors of organ/space SSI were older age, smoking, vascular disease, prior MRSA infection, greater estimated blood loss, and lymphadenectomy or bowel resection. SSI resulted in a $5447 median increase in 30-day cost. Conclusions Our findings are useful to individualize preoperative risk counseling. Hyperglycemia and smoking are modifiable, and minimally invasive surgical approaches should be the preferred surgical route because they decrease SSI events. Judicious use of lymphadenectomy may decrease SSI. Thirty-day postoperative costs are considerably increased when SSI occurs.
KW - Cost-effective surgical care
KW - Endometrial cancer
KW - Minimally invasive surgery
KW - Surgical site infection
UR - http://www.scopus.com/inward/record.url?scp=84879124404&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879124404&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2013.03.022
DO - 10.1016/j.ygyno.2013.03.022
M3 - Article
C2 - 23558053
AN - SCOPUS:84879124404
SN - 0090-8258
VL - 130
SP - 100
EP - 106
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 1
ER -